Tretinoin (CAS 302-79-4): Chemical Identity and Structure
Tretinoin is the all-trans isomer of retinoic acid, also written ATRA. Its molecular formula is C20H28O2 and its molar mass is 300.44 g/mol. The structure has three parts: a substituted β-ionone ring, an alternating polyene chain of four conjugated double bonds in the all-trans configuration, and a terminal carboxylic acid group. That fully extended all-trans geometry is the reason the molecule binds its nuclear receptor targets; on exposure to light or heat it isomerises to 13-cis retinoic acid and other cis isomers, which is the central stability problem in manufacture and storage. The material is a yellow to orange crystalline powder, practically insoluble in water, and soluble in dimethyl sulfoxide and many organic solvents.
Where Tretinoin Is Used
Three applications account for almost all demand. Topically it is the reference comedolytic agent for acne vulgaris, where it normalises follicular keratinisation and accelerates replacement of the outer skin layer; visible improvement usually takes 8–12 weeks. Systemically, as all-trans retinoic acid, it is a differentiation therapy for acute promyelocytic leukaemia, typically dosed at 45 mg per square metre of body surface per day divided into two administrations. It is also used in photoaging formulations and as an analytical reference standard for retinoic acid assays. In all cases the material is supplied as a pharmaceutical-grade active ingredient or as a research reference, not as a bulk industrial chemical.
Manufacturing Route and Impurity Control
Industrial synthesis proceeds from β-ionone through a sequence of condensation and rearrangement steps to retinal, followed by selective oxidation of the aldehyde to the carboxylic acid. The final purification is normally a crystallisation and, where a high isomeric purity is specified, a chromatographic polish. Because the polyene chain is sensitive to both oxygen and light, the whole route runs under nitrogen and under yellow or amber light. Critical quality attributes are all-trans content against total retinoic acid, the level of 13-cis isomer, related substances and residual solvents, with the latter controlled under ICH Q3C and manufacture conducted under the GMP framework of ICH Q7. Pharmacopoeial monographs, including the USP–NF monograph for tretinoin, set the official assay and identification tests for the substance.
Typical Specification Highlights
| Parameter | Typical requirement | Method |
|---|---|---|
| Assay (all-trans retinoic acid), dried basis | 98.0–102.0% | HPLC with UV detection, pharmacopoeial monograph |
| 13-cis isomer | Not more than the monograph limit | HPLC, isomeric separation |
| Related substances | Individual and total limits per monograph | HPLC gradient |
| Water | ≤ 0.5% | Karl Fischer, ASTM E203 |
| Residual solvents | Within ICH Q3C limits | Headspace gas chromatography |
| Appearance | Yellow to orange crystalline powder | Visual |
Handling, Packaging and Stability
Tretinoin is light-sensitive and oxygen-sensitive, so the standard pack is an amber glass bottle or a double polyethylene-lined fibre drum, often nitrogen-flushed, with storage at 2–8 °C. Stability studies should track isomeric conversion rather than assay alone, because an all-trans content that passes on release can drift during a long supply chain. Dispensing and sampling are done under controlled light, and retained samples are held under the same conditions as the commercial stock. The substance is not a narcotic or a controlled precursor; it is handled as a prescription active pharmaceutical ingredient with the corresponding documentation, and shipments move with a certificate of analysis, a material safety data sheet and, where required, a written confirmation of the manufacturing and expiry dates.
Frequently Asked Questions
Q: What is tretinoin used for?
A: It is used topically for acne vulgaris, systemically as all-trans retinoic acid for acute promyelocytic leukaemia at about 45 mg per square metre per day divided into two doses, and in photoaging formulations. It also serves as a reference standard for retinoic acid testing.
Q: Is tretinoin the same as vitamin A?
A: No. Tretinoin is the carboxylic acid form of vitamin A, also called all-trans retinoic acid. Retinol, retinal and retinyl esters are different molecules at different oxidation states, and they are not interchangeable in formulation work.
Q: Why is the all-trans isomer so important?
A: Only the fully extended all-trans configuration fits the retinoic acid receptors; cis isomers show much lower activity. Light and heat convert all-trans to 13-cis, so isomeric purity is a release-critical specification, not a cosmetic one.
Q: How should tretinoin be stored?
A: In a sealed, light-resistant container under nitrogen at 2–8 °C. Dispensing should be done under subdued light, and stability studies should monitor isomer content as well as assay.
Q: Which tests control purity of the raw material?
A: Assay by HPLC against the pharmacopoeial monograph, isomeric ratio by HPLC, related substances by gradient HPLC, water by Karl Fischer, and residual solvents by headspace gas chromatography within ICH Q3C limits.
Q: Is tretinoin a controlled substance?
A: It is not a narcotic or listed precursor. It is a prescription active pharmaceutical ingredient, so supply requires GMP documentation, a certificate of analysis and a material safety data sheet rather than narcotic permits.
